<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21640" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chronic Fatigue Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sapra</surname>
            <given-names>Amit</given-names>
          </name>
          <aff>Southern Illinois University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bhandari</surname>
            <given-names>Priyanka</given-names>
          </name>
          <aff>Southern Illinois University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amit Sapra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Priyanka Bhandari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>21</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21640.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Chronic fatigue syndrome, also known as myalgic encephalomyelitis, is a complex multisystem disease commonly characterized by severe fatigue, cognitive dysfunction, sleep problems, autonomic dysfunction, and post-exertional malaise, which can severely impair patients' ability to conduct the activities of daily living. Therefore, early diagnosis and prompt treatment are critical to prevent high morbidity and its overwhelming effect on the quality of life. This activity reviews the evaluation and treatment of chronic fatigue syndrome and highlights the interprofessional team's role in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of chronic fatigue syndrome.</p></list-item><list-item><p>Review the appropriate evaluation of chronic fatigue syndrome.</p></list-item><list-item><p>Outline the management options available for chronic fatigue syndrome.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and communication to ensure the best outcomes for patients with chronic fatigue syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21640&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21640">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21640.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Chronic fatigue syndrome (CFS) is a chronic disease that potentially affects about two million Americans.<xref ref-type="bibr" rid="article-21640.r1">[1]</xref>&#x000a0;The United States Public Health Services initially described it during an epidemiological study of Los Angeles County during the summer of 1934. Chronic fatigue syndrome, also called myalgic encephalomyelitis, is a complex multisystem disease commonly characterized by severe fatigue, cognitive dysfunction, sleep problems, autonomic dysfunction, and post-exertional malaise severely impairing activities of daily living.&#x000a0;Outcomes become worse due to the condition remaining undiagnosed for years, secondary to inadequate medical teaching on the subject, provider bias,&#x000a0;and confusion regarding diagnosis and treatment of the disease.<xref ref-type="bibr" rid="article-21640.r1">[1]</xref></p>
        <p>CFS does not only present with fatigue but also cognitive dysfunction and impairment of&#x000a0;routine functioning that persists for six months or more.&#x000a0;CFS is a biological condition, not a psychological disorder. The exact pathogenesis&#x000a0;remains to be fully understood. Various&#x000a0;mechanisms and biochemical changes have been implicated that affect immune function, hormonal regulation, and response to oxidative stress. It also includes natural killer cell dysfunction and/or T-cell dysfunction, elevated cytokines, and autoantibodies.<xref ref-type="bibr" rid="article-21640.r2">[2]</xref>&#x000a0;The infectious&#x000a0;cause has been proposed, but no causal relationship has been identified.<xref ref-type="bibr" rid="article-21640.r3">[3]</xref></p>
        <p>Patients with CFS can sometimes present to the emergency department with a list of complex symptoms, such as orthostatic intolerance, postexertional malaise (PEM), fatigue, and diarrhea.<xref ref-type="bibr" rid="article-21640.r4">[4]</xref></p>
      </sec>
      <sec id="article-21640.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of chronic fatigue syndrome (CFS) is controversial, complicated, and incompletely understood. Controversy exists about single versus multiple causations.&#x000a0;Many theories exist regarding the involvement of infections, the immune system, and genetics in this complex interplay.</p>
        <p>
<bold>Genetics</bold>
</p>
        <p>Increasing evidence supports the role of genetic susceptibility in patients with CFS. Many studies have reported the role of family history in the development of CFS or similar fatigue-like symptoms.<xref ref-type="bibr" rid="article-21640.r5">[5]</xref>&#x000a0;Studies from the twin registry also have shown increased familial and genetic predisposition to the condition.<xref ref-type="bibr" rid="article-21640.r6">[6]</xref><xref ref-type="bibr" rid="article-21640.r7">[7]</xref>&#x000a0;A study&#x000a0;observed variability in the expression of specific genes in patients with CFS, particularly after exercise, which affects the metabolism and immune responses.<xref ref-type="bibr" rid="article-21640.r8">[8]</xref>&#x000a0;In another study, an association was reported between CFS and specific genetic mutations and viral infections.<xref ref-type="bibr" rid="article-21640.r9">[9]</xref></p>
        <p>
<bold>Infection</bold>
</p>
        <p>Various infectious etiologies, including the Epstein-Barr virus (EBV), the human herpesvirus (HHV)-6, and the human parvovirus B19, are hypothesized to trigger the disease.<xref ref-type="bibr" rid="article-21640.r10">[10]</xref><xref ref-type="bibr" rid="article-21640.r11">[11]</xref><xref ref-type="bibr" rid="article-21640.r12">[12]</xref><xref ref-type="bibr" rid="article-21640.r13">[13]</xref></p>
        <p>Speculations are that in a few patients, the acquisition of viral infections like infectious mononucleosis triggers the onset of the disease process.<xref ref-type="bibr" rid="article-21640.r14">[14]</xref><xref ref-type="bibr" rid="article-21640.r15">[15]</xref><xref ref-type="bibr" rid="article-21640.r16">[16]</xref></p>
        <p>Researchers have detected anti-HHV-6 IgM antibodies and HHV-6 antigens more commonly in the peripheral blood of patients with chronic fatigue syndrome than in the general population, indicating higher prevalence and higher reactivation of the virus in this cohort.<xref ref-type="bibr" rid="article-21640.r17">[17]</xref><xref ref-type="bibr" rid="article-21640.r18">[18]</xref><xref ref-type="bibr" rid="article-21640.r19">[19]</xref><xref ref-type="bibr" rid="article-21640.r20">[20]</xref></p>
        <p>Parvovirus B19, both with and without viremia, has been implicated in developing and triggering chronic fatigue syndrome.<xref ref-type="bibr" rid="article-21640.r21">[21]</xref>&#x000a0;These patients have higher levels of tumor necrosis factor and interferon-gamma.<xref ref-type="bibr" rid="article-21640.r22">[22]</xref></p>
        <p>
<bold>Alterations in the Immune System</bold>
</p>
        <p>It has been observed that alterations in the levels of CD 21+ CD19+ and activated CD5+ cells in patients with chronic fatigue syndrome.<xref ref-type="bibr" rid="article-21640.r23">[23]</xref></p>
        <p>There is also a reported decrease in transitional B cells and plasmablasts and an increase in the population of CD24+ B cells in these patients.<xref ref-type="bibr" rid="article-21640.r24">[24]</xref><xref ref-type="bibr" rid="article-21640.r25">[25]</xref>&#x000a0;Researchers have also found elevations in the levels of immunoglobulins IgG in several studies, again pointing to alteration in the immune functioning of these patients.<xref ref-type="bibr" rid="article-21640.r26">[26]</xref><xref ref-type="bibr" rid="article-21640.r27">[27]</xref>&#x000a0;Several studies have also described the presence of autoantibodies against nuclear and membrane structures as well as against neurotransmitter receptors.<xref ref-type="bibr" rid="article-21640.r28">[28]</xref><xref ref-type="bibr" rid="article-21640.r29">[29]</xref><xref ref-type="bibr" rid="article-21640.r30">[30]</xref><xref ref-type="bibr" rid="article-21640.r31">[31]</xref></p>
      </sec>
      <sec id="article-21640.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Studies have given different prevalence rates for chronic fatigue syndrome based on the type of definition used, the type of population surveyed, and the study design used.<xref ref-type="bibr" rid="article-21640.r32">[32]</xref>&#x000a0;Studies have given a current prevalence rate ranging from 0.007% to 2.8% in the general adult U.S. population and from 0.006% to 3.0% in the primary care population.<xref ref-type="bibr" rid="article-21640.r33">[33]</xref><xref ref-type="bibr" rid="article-21640.r34">[34]</xref><xref ref-type="bibr" rid="article-21640.r35">[35]</xref><xref ref-type="bibr" rid="article-21640.r36">[36]</xref><xref ref-type="bibr" rid="article-21640.r37">[37]</xref>&#x000a0;Studies conducted from 1993 through 1999 reported a prevalence of 0.004% to 0.56%, whereas more recent studies have reported prevalence rates of 0.24% to 2.6%.<xref ref-type="bibr" rid="article-21640.r38">[38]</xref>&#x000a0;As per the study conducted by Bierl and colleagues in 2004, about 2.2 million American adults suffer from CFS-like illness.<xref ref-type="bibr" rid="article-21640.r39">[39]</xref>&#x000a0;They estimated that about 1,197 people per 100,000 suffer from CSF and CFS-like illnesses.<xref ref-type="bibr" rid="article-21640.r39">[39]</xref></p>
        <p>Studies have found that the prevalence is significantly higher&#x000a0;between 40&#x000a0;and 70 years of age.<xref ref-type="bibr" rid="article-21640.r40">[40]</xref>&#x000a0;Women suffer from it more often than men.<xref ref-type="bibr" rid="article-21640.r41">[41]</xref>&#x000a0;The prevalence seems higher in the White population than in the non-White population.<xref ref-type="bibr" rid="article-21640.r41">[41]</xref>&#x000a0;Studies have also reported a markedly higher prevalence in the low-income cohort than in the higher-income and higher-educated cohort, suggesting the role of social risk factors such as stress in the causation of CFS.<xref ref-type="bibr" rid="article-21640.r41">[41]</xref><xref ref-type="bibr" rid="article-21640.r39">[39]</xref><xref ref-type="bibr" rid="article-21640.r40">[40]</xref>&#x000a0;No regional differences were noticed in the country as far as CFS prevalence is concerned.<xref ref-type="bibr" rid="article-21640.r39">[39]</xref></p>
      </sec>
      <sec id="article-21640.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Alterations in the Immune System</bold>
</p>
        <p>The pathophysiological&#x000a0;mechanisms leading to chronic fatigue syndrome are not entirely understood.<xref ref-type="bibr" rid="article-21640.r42">[42]</xref>&#x000a0;It is proposed that an alteration in the nervous system occurs secondary to the body&#x02019;s unintended responses to commonly encountered antigens leading to changes in the cell-mediated immunity, activation of oxidative pathways, and alteration in the neuroendocrinal and autoimmune responses against neurons.<xref ref-type="bibr" rid="article-21640.r43">[43]</xref>&#x000a0;Multiple studies have shown alterations in the functioning of the natural killer (NK) cells, interleukins profile, and the decreased response of T cells to specific antigens.<xref ref-type="bibr" rid="article-21640.r42">[42]</xref></p>
        <p>There is evidence of ongoing inflammation, as indicated by increased production of various proinflammatory interleukins, which also explains malaise and flu-like symptoms&#x000a0;about which the patients often complain.<xref ref-type="bibr" rid="article-21640.r42">[42]</xref></p>
        <p>
<bold>Increased Oxidative Stress</bold>
</p>
        <p>Some studies report chronic fatigue syndrome patients to have significantly increased oxidative stress, which plays a vital role in the etiopathogenesis of the disease. There is an increase in oxidative stress biomarkers like oxidized LDL and certain prostaglandins and, at the same time, a decrease in the amounts of the antioxidants like glutathione.<xref ref-type="bibr" rid="article-21640.r44">[44]</xref><xref ref-type="bibr" rid="article-21640.r45">[45]</xref>&#x000a0;The oxidative damage transforms the fatty acids and proteins into immunogenic targets.<xref ref-type="bibr" rid="article-21640.r46">[46]</xref>&#x000a0;The free radicals also damage the electron transport chain (causing impaired energy production) and mitochondria.<xref ref-type="bibr" rid="article-21640.r47">[47]</xref>&#x000a0;The mechanism&#x000a0;underlying mitochondrial dysregulation is not entirely known.<xref ref-type="bibr" rid="article-21640.r48">[48]</xref><xref ref-type="bibr" rid="article-21640.r49">[49]</xref><xref ref-type="bibr" rid="article-21640.r50">[50]</xref></p>
        <p>
<bold>Oligoadenylate Synthetase/RNase L Pathway</bold>
</p>
        <p>The association between the onset of CFS with a viral infection has always been speculated. One of the interferon-activated antiviral pathways involves activating the 2&#x02019;-5&#x02019;-oligoadenylate (2-5A) synthetase/RNase L system.<xref ref-type="bibr" rid="article-21640.r51">[51]</xref>&#x000a0;Severe deregulation of this antiviral pathway occurs in CFS, which leads to a decrease in the apoptotic activity in the cells.</p>
        <p>
<bold>Alteration of Natural Killer (NK) Cells</bold>
</p>
        <p>Studies have shown a lower number of CD3-CD57 white cells lymphocytes, which are a type of NK cell, whereas the levels of the cytotoxic T cells were not changed.<xref ref-type="bibr" rid="article-21640.r52">[52]</xref><xref ref-type="bibr" rid="article-21640.r53">[53]</xref><xref ref-type="bibr" rid="article-21640.r54">[54]</xref></p>
        <p>
<bold>B Cell Impairment</bold>
</p>
        <p>The profile of B cell subpopulations may differ in CFS compared with controls. CFS is associated with increased production of the CD20+ CD5+ B cell phenotypes correlating with increased autoantibody production and overexpression of CD21 markers acting as receptors for some viruses.<xref ref-type="bibr" rid="article-21640.r24">[24]</xref><xref ref-type="bibr" rid="article-21640.r25">[25]</xref></p>
        <p>
<bold>Immunoglobulins</bold>
</p>
        <p>There is also an alteration in the immunoglobulin number and distribution in patients with chronic fatigue syndrome. The total immunoglobulin G (IgG) level, particularly subclasses IgG1 and IgG3, is substantially lower. In contrast, there is an increase in IgA and IgM serum levels against the lipopolysaccharides of the normal gram-negative bacteria due to alterations in gut permeability.<xref ref-type="bibr" rid="article-21640.r55">[55]</xref><xref ref-type="bibr" rid="article-21640.r56">[56]</xref>&#x000a0;These can also serve as corroborative evidence for the provider about the patient suffering from CFS.</p>
        <p>
<bold>Autoimmunity</bold>
</p>
        <p>Studies have also detected autoantibodies against certain neurotransmitters and neurons, leading to alterations in neurotransmitter response, sleep patterns, and neurocognition.<xref ref-type="bibr" rid="article-21640.r30">[30]</xref><xref ref-type="bibr" rid="article-21640.r57">[57]</xref>&#x000a0;Researchers have found antinuclear antibodies (ANA), anti-dsDNA antibodies, and antibodies against neuronal and endothelial cells in these patients.<xref ref-type="bibr" rid="article-21640.r58">[58]</xref>&#x000a0;Moreover, antibodies against the muscarinic M1 acetylcholine beta-adrenergic receptors have been detected in these patients.<xref ref-type="bibr" rid="article-21640.r30">[30]</xref><xref ref-type="bibr" rid="article-21640.r13">[13]</xref>&#x000a0;Disturbance in these receptors could explain symptoms of autonomic dysregulation in these patients.<xref ref-type="bibr" rid="article-21640.r59">[59]</xref></p>
        <p>
<bold>Alterations in the Central Nervous System</bold>
</p>
        <p>
<bold>Neuroinflammation and Role of Glial Cells</bold>
</p>
        <p>The presence of proinflammatory changes causes speculation about the involvement of neuroinflammation in the pathogenesis and clinical presentation of the disease process.<xref ref-type="bibr" rid="article-21640.r60">[60]</xref>&#x000a0;Multiple studies show that the constant proinflammatory state that occurs in CFS causes activation of glial cells, specifically microglia and astrocytes. These activated glial cells produce the expression of a translator protein, which appears to activate inflammation in the central nervous system.<xref ref-type="bibr" rid="article-21640.r61">[61]</xref>&#x000a0;The increase in glial activation leads to an increase in neuronal excitation and neuronal inflammation, which is supposed to be the leading cause of chronic pain symptoms in these patients.<xref ref-type="bibr" rid="article-21640.r62">[62]</xref>&#x000a0;Studies are also evaluating the role of &#x0201c;glial toxins&#x0201d; produced by multiple viruses and bacteria, leading to direct damage to these glial cells.<xref ref-type="bibr" rid="article-21640.r63">[63]</xref></p>
        <p>
<bold>Neuronal Sensitization</bold>
</p>
        <p>The hypothesis about neuronal sensitization&#x000a0;proposes an exaggerated response to painful stimuli in patients with CFS due to the chemical and structural changes at the central nervous system level.<xref ref-type="bibr" rid="article-21640.r62">[62]</xref>&#x000a0;This exaggerated response leads to the formation of sensitized neurons that keep the stimulus going due to the process of &#x0201c;kindling.&#x0201d;</p>
        <p>
<bold>Alterations in the Neuroendocrine System</bold>
</p>
        <p>
<bold>Changes in Serotonin Transmission</bold>
</p>
        <p>Central fatigue, a key symptom in patients with chronic fatigue syndrome, is hypothesized to be due to excess levels of serotonin and its metabolites in the central nervous system of these patients.<xref ref-type="bibr" rid="article-21640.r64">[64]</xref>&#x000a0;The excess serotonin leads to inhibition of the action potential generation and thus reduced motor activity and appears to be a leading contributor to the fatigue symptoms of these patients.<xref ref-type="bibr" rid="article-21640.r65">[65]</xref><xref ref-type="bibr" rid="article-21640.r66">[66]</xref></p>
        <p>
<bold>Hypocortisolism</bold>
</p>
        <p>It is also theorized that there are low circulating cortisol levels in patients with chronic fatigue syndrome secondary to dysfunction in the hypothalamic-pituitary axis (HPA). Cortisol is the principal hormone of the HPA and leads to the cortisol awakening response (CAR). This response is deficient in patients with CFS, leading to the post-exertional malaise.<xref ref-type="bibr" rid="article-21640.r67">[67]</xref></p>
        <p>
<bold>Genetic Predisposition</bold>
</p>
        <p>Studies have shown an interaction between changes in the genes secondary to changes in the environment, leading to epigenetic modification. DNA methylation appears to be the most studied of these epigenetic modifications that can alter the expression of the gene concerning the environmental stimuli and lead to the development of the disease process.<xref ref-type="bibr" rid="article-21640.r68">[68]</xref></p>
      </sec>
      <sec id="article-21640.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The hallmark symptom of chronic fatigue syndrome is the post-exertional fatigue associated with numerous neurological, cardiovascular, respiratory,&#x000a0;and gastrointestinal complaints.<xref ref-type="bibr" rid="article-21640.r68">[68]</xref>&#x000a0;The fatigue described by patients is worsened by exertion and low upright posture, not relieved by rest, and no medical reason can be found.<xref ref-type="bibr" rid="article-21640.r69">[69]</xref>&#x000a0;Patients often state that they have had high fitness levels before the onset of fatigue.<xref ref-type="bibr" rid="article-21640.r70">[70]</xref>&#x000a0;Patients describe the beginning of the fatigue rather abruptly, typically associated with a flu-like illness.<xref ref-type="bibr" rid="article-21640.r71">[71]</xref>&#x000a0;They also describe post-exertional malaise, where the regular activity is followed by symptoms of worsening discomfort and fatigue, with delayed recovery, usually taking more than one day.<xref ref-type="bibr" rid="article-21640.r72">[72]</xref>&#x000a0;Patients also complain of new-onset chronic headaches with varied weekly fluctuations.<xref ref-type="bibr" rid="article-21640.r72">[72]</xref>&#x000a0;Muscle pain is seen more commonly in pediatric patients and also could be a feature of comorbid fibromyalgia.<xref ref-type="bibr" rid="article-21640.r73">[73]</xref></p>
        <p>Patients can also report joint pains, and there could be an associated autoimmune rheumatological condition.<xref ref-type="bibr" rid="article-21640.r73">[73]</xref>&#x000a0;There are often reports of disturbed sleep and not feeling fresh the next morning, leading to daytime hypersomnolence and nighttime insomnia.<xref ref-type="bibr" rid="article-21640.r72">[72]</xref>&#x000a0;Also, there are complaints of cognitive decline with slowed mental processing speed, poor learning abilities, impaired processing of new information, memory decline, decreased attention span, and poor multitasking ability.<xref ref-type="bibr" rid="article-21640.r74">[74]</xref>&#x000a0;Besides, these patients can also have autonomic manifestations, including nausea, vomiting, drenching night sweats, dizziness, and intolerance to alcohol and other medications.<xref ref-type="bibr" rid="article-21640.r75">[75]</xref><xref ref-type="bibr" rid="article-21640.r76">[76]</xref>&#x000a0;Patients can also exhibit symptoms of uncontrolled anxiety, panic attacks, and impaired social functioning.<xref ref-type="bibr" rid="article-21640.r77">[77]</xref><xref ref-type="bibr" rid="article-21640.r78">[78]</xref>&#x000a0;Most of these patients have decreased ability to work.<xref ref-type="bibr" rid="article-21640.r79">[79]</xref></p>
      </sec>
      <sec id="article-21640.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Chronic fatigue syndrome (CFS)&#x000a0;is a diagnosis made on clinical examination after excluding other possible etiologies.</p>
        <p>Initially, when the etiological considerations were considered mainly viral in origin, the Center for Disease Control and Prevention (CDC) U.S.A., in 1988, came up with the criterion for the same with the primary focus on the physical symptoms. The Oxford criterion was developed in 1991 and defined a case of chronic fatigue syndrome where mild to severe symptoms of fatigue, myalgias, and tiredness were present.<xref ref-type="bibr" rid="article-21640.r77">[77]</xref>&#x000a0;The Oxford criterion states fatigue to be the primary symptom which should have a definite beginning and should be severe, disabling, and affecting mental and physical functions. These symptoms should have been present for a minimum of six months and should be affecting the patient more than fifty percent of the time. There was a need for other symptoms like myalgias, mood, and sleep disturbances to be present as well. Exclusion criteria included those known to have a medical condition that caused fatigue and those diagnosed with mental health disorders like schizophrenia, mania, depression, eating disorders, substance abuse, or known organic brain pathology.<xref ref-type="bibr" rid="article-21640.r77">[77]</xref></p>
        <p>Subsequent conclusions stated that the Oxford criterion was over-inclusive and had a low threshold that recruited patients with milder symptoms, leading to the generalization of treatments for all patients. Hence, the treatment guidelines could not be generalized to patients with severe symptoms, chronic pain, post-exertional malaise, and other conditions that mimicked chronic fatigue syndrome.<xref ref-type="bibr" rid="article-21640.r80">[80]</xref><xref ref-type="bibr" rid="article-21640.r81">[81]</xref><xref ref-type="bibr" rid="article-21640.r82">[82]</xref></p>
        <p>Considering the need for revision of the diagnostic criterion, the CDC, in the year 1994, came up with a broader definition for chronic fatigue syndrome developed by Fakuda and colleagues.<xref ref-type="bibr" rid="article-21640.r83">[83]</xref>&#x000a0;As per these criteria, the patient should have severe fatigue for more than six months as well as at least four of the following symptoms: a new type of headache or a change in the pattern or severity of the headache, myalgias, pain in multiple joints, post-exertional malaise lasting more than one day, sore throat, tender lymph nodes, unrefreshing sleep and significant impairment in short term memory or concentration.</p>
        <p>The modified CDC criterion was extensively used until 2015, when the institute of medicine (IOM)&#x000a0;proposed the criterion to diagnose chronic fatigue syndrome.<xref ref-type="bibr" rid="article-21640.r84">[84]</xref>&#x000a0;The current IOM criterion was developed after reviewing the 1994 CDC guidelines by Fakuda and colleagues, the 2003 Canadian clinical case definition for CFS, the 2007 clinical guidelines for CFS from the British national institute for health and clinical excellence (NICE) along with the 2010 revised Canadian consensus criteria for CFS (Revised CCC).<xref ref-type="bibr" rid="article-21640.r84">[84]</xref></p>
        <p>
<bold>2015 IOM Diagnostic Criteria for CFS</bold>
</p>
        <p>Diagnosis of chronic fatigue syndrome requires the presence of the following three symptoms for more than six months as well as the intensity of the symptoms should be moderate or severe for at least 50% of the time.</p>
        <p>The three main symptoms include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fatigue - A noticeable decrease or impairment in a patient's ability to engage in activities they would have enjoyed before the onset of the illness. This impairment continues for more than six months and is associated with new-onset severe fatigue unrelated to exertion and not relieved by rest.</p>
          </list-item>
          <list-item>
            <p>Post-exertional malaise - Patients experience worsening symptoms and function after exposure to physical or cognitive stressors, which they previously well tolerated.</p>
          </list-item>
          <list-item>
            <p>Unrefreshing sleep - patients feel tired after a night's sleep.</p>
          </list-item>
        </list>
        <p>Criterion fulfillment for diagnosis requires the three above-stated symptoms plus one of the additional below-mentioned symptoms.</p>
        <list list-type="bullet">
          <list-item>
            <p>Cognitive impairment - Problems with the thought or executive function worsened by exertion, effort, stress, or time pressure.</p>
          </list-item>
          <list-item>
            <p>Orthostatic intolerance - Worsening of symptoms upon assuming and maintaining an upright posture. Although not necessarily abolished, symptoms are improved by lying back down or elevating the feet.<xref ref-type="bibr" rid="article-21640.r84">[84]</xref></p>
          </list-item>
        </list>
        <p>The typical approach to a patient with chronic fatigue should begin with a history and physical examination, identifying the underlying symptoms and ruling out any serious illnesses. The providers should use a validated clinical questionnaire like the DePaul symptom questionnaire or the Center for Disease Control Symptom Inventory.<xref ref-type="bibr" rid="article-21640.r85">[85]</xref><xref ref-type="bibr" rid="article-21640.r86">[86]</xref></p>
        <p>There are no pathognomonic or diagnostic tests or single biomarkers of CFS. Tests to rule out other etiologies are undertaken in the context of the particular patient. The standard laboratory tests include urinalysis, complete blood count with differential, blood chemistries, thyroid function tests, muscle enzymes like creatine kinases, and C- reactive protein.<xref ref-type="bibr" rid="article-21640.r83">[83]</xref>&#x000a0;The national institute for clinical excellence (NICE) also conducts tests for gluten sensitivity and recommends using immunoglobulin A endomysial antibodies, urine drug screening, and rheumatological antibodies as indicated. It also recommends against using viral titers unless necessary after the patient's clinical examination.<xref ref-type="bibr" rid="article-21640.r87">[87]</xref></p>
      </sec>
      <sec id="article-21640.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Non-Pharmacologic Management</bold>
</p>
        <p>There is some debate about the appropriate treatment of chronic fatigue syndrome. A randomized control trial conducted in 2011 in the United Kingdom compared the effectiveness and safety of cognitive-behavioral therapy (CBT), graded exercise therapy (GET), adaptive pacing therapy (APT), and specialist medical care in the management of chronic fatigue syndrome. Overcoming fatigue and improvement of physical function were taken as measures of effectiveness, while safety assessment comprised recording all adverse effects. The results showed that CBT and GET improved outcomes when used together, whereas APT was not a helpful addition.<xref ref-type="bibr" rid="article-21640.r80">[80]</xref></p>
        <p>Further analysis of the available data questions the statistical significance of the benefit of CBT and GET.<xref ref-type="bibr" rid="article-21640.r88">[88]</xref>&#x000a0;The CDC recommends treating associated depression, stress, and anxiety but states that this is not a cure for CFS. Techniques like deep breathing and muscle relaxation, massage, yoga, and tai chi may be of benefit.</p>
        <p>Treatment for any comorbid condition should be undertaken to minimize symptom burden.<xref ref-type="bibr" rid="article-21640.r83">[83]</xref><xref ref-type="bibr" rid="article-21640.r89">[89]</xref></p>
        <p>During the CBT sessions, the therapist emphasizes the role of the thought process and its impact on the patient's actions and feelings and recognizes behaviors that cause them to feel more tired and minimize them. Multiple trials and Cochrane reviews have shown the positive benefits of CBT on improving fatigue, mood, and post-exertional malaise in both adolescent and adult patients.<xref ref-type="bibr" rid="article-21640.r89">[89]</xref><xref ref-type="bibr" rid="article-21640.r90">[90]</xref><xref ref-type="bibr" rid="article-21640.r91">[91]</xref><xref ref-type="bibr" rid="article-21640.r92">[92]</xref>&#x000a0;Studies have also shown lower school absences when CBT is provided to the adolescent population.<xref ref-type="bibr" rid="article-21640.r93">[93]</xref></p>
        <p>GET involves a supervised, gradual increase in the duration and intensity of physical activity. After the PACE trial, this therapy got much publicity, which showed effectiveness for fatigue and functional impairment with the GET.<xref ref-type="bibr" rid="article-21640.r80">[80]</xref> The trial encouraged the participants to gradually increase the timing of their physical activity to a final goal of 30 minutes, spread over 52 weeks to a final goal of 30 minutes of light exercise five days per week while trying to avoid overexertion. Other studies have also supported its efficacy.<xref ref-type="bibr" rid="article-21640.r94">[94]</xref><xref ref-type="bibr" rid="article-21640.r95">[95]</xref><xref ref-type="bibr" rid="article-21640.r96">[96]</xref>&#x000a0;However, CBT and GET can be adjunct management options, but they are not curative.</p>
        <p>Activity management is also called pacing. The goal is to learn to balance rest and activity to avoid flare-ups. These can be caused by exertion that patients cannot tolerate.</p>
        <p>
<bold>Pharmacologic Management</bold>
</p>
        <p>
<bold>Pain Medications</bold>
</p>
        <p>Nonsteroidal anti-inflammatory drugs (NSAIDs), including COX-2 inhibitors, are used due to their action in relieving pain and associated inflammation.<xref ref-type="bibr" rid="article-21640.r97">[97]</xref><xref ref-type="bibr" rid="article-21640.r98">[98]</xref>&#x000a0;Opioid medications are addictive and hence only used for very severe cases for the shortest possible duration.<xref ref-type="bibr" rid="article-21640.r99">[99]</xref></p>
        <p>
<bold>Tricyclic Antidepressants</bold>
</p>
        <p>Multiple tricyclic antidepressants have shown varying degrees of success in improving sleep, pain levels, and fatigue severity.<xref ref-type="bibr" rid="article-21640.r97">[97]</xref>&#x000a0;The doses used here are typically lower than the doses used in the treatment of depression.<xref ref-type="bibr" rid="article-21640.r100">[100]</xref></p>
        <p>
<bold>Selective Serotonin Reuptake Inhibitors (SSRI) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)</bold>
</p>
        <p>Many SSRIs like fluoxetine, sertraline, and paroxetine have been used to treat depression and anxiety, which either accompany the disease process of chronic fatigue syndrome or occur as a consequence. SNRIs have the added benefit of providing neuropathic pain relief besides the antidepressant effect. However, neither SSRIs nor SSNRIs directly affect the underlying pathophysiology of the disease process.<xref ref-type="bibr" rid="article-21640.r80">[80]</xref></p>
        <p>
<bold>Antiviral Therapy</bold>
</p>
        <p>Several antiviral medications have been tried in these patients, but most of these studies have been inconclusive.<xref ref-type="bibr" rid="article-21640.r101">[101]</xref><xref ref-type="bibr" rid="article-21640.r102">[102]</xref>&#x000a0;Randomized controlled trials (RCTs) comparing the effect of nucleotide analog inhibitors like acyclovir, valacyclovir, and ganciclovir, versus placebo, have shown no difference in symptom control.<xref ref-type="bibr" rid="article-21640.r103">[103]</xref>&#x000a0;Studies using interferons versus placebo in chronic fatigue syndrome also did not show evidence of clear benefit.<xref ref-type="bibr" rid="article-21640.r104">[104]</xref></p>
        <p>
<bold>Immunoglobulin</bold>
</p>
        <p>A systemic review conducted by Whiting et al. in 2001 evaluated five&#x000a0;randomized controlled trials on the use of immunoglobulins in patients with chronic fatigue syndrome. It revealed positive results in four of them.<xref ref-type="bibr" rid="article-21640.r80">[80]</xref>&#x000a0;Unfortunately, other studies did not report any benefit and, in fact, concluded the potential dangers of the immunoglobulins.</p>
        <p>
<bold>Corticosteroids</bold>
</p>
        <p>Multiple RCTs and systemic reviews performed with steroids in 2005 showed varying responses. One systemic review conducted in 2015 showed a weak benefit from low-dose hydrocortisone, but the effect was only short-lived and was associated with adverse effects.<xref ref-type="bibr" rid="article-21640.r105">[105]</xref></p>
        <p>
<bold>Complementary and Alternative Medicines</bold>
</p>
        <p>Systemic reviews of the studies using essential fatty acids, magnesium, acetyl-l-carnitine, vitamin B12, and antioxidants have shown only partial response and require further studies to&#x000a0;establish a definitive relation.<xref ref-type="bibr" rid="article-21640.r106">[106]</xref></p>
        <p>
<bold>Newer Treatments and Trials</bold>
</p>
        <p>
<bold>Rintatolimod</bold>
</p>
        <p>Rintatolimod is a newly approved immunomodulator and an antiviral drug for treating chronic fatigue syndrome in Canada and Europe.<xref ref-type="bibr" rid="article-21640.r107">[107]</xref>&#x000a0;An RCT published in the journal of the American medical association (JAMA) in 2001 showed the medication to be of some benefit in these patients.<xref ref-type="bibr" rid="article-21640.r108">[108]</xref>&#x000a0;The U.S. FDA rejected the drug to be marketed in the U.S. for CFS treatment, citing insufficient safety and efficacy data.</p>
        <p>
<bold>Rituximab</bold>
</p>
        <p>Rituximab is an anti-CD20 monoclonal antibody causing the depletion of B cells. An initial small double-blind, placebo-controlled trial of 30 patients with CFS receiving rituximab showed some benefit, leading the researchers to hypothesize that B cells might have a significant role in the pathogenesis of some patients&#x000a0;with chronic fatigue syndrome.<xref ref-type="bibr" rid="article-21640.r109">[109]</xref>&#x000a0;However, a more extensive study showed no fatigue difference between patients who received rituximab versus those who did not.&#x000a0;Also, patients receiving rituximab showed more adverse effects, including neutropenia and infections.<xref ref-type="bibr" rid="article-21640.r110">[110]</xref></p>
        <p>
<bold>Fecal Microbiota Transplantation</bold>
</p>
        <p>Alteration in gastrointestinal (GI) microbiota in CFS patients has been hypothesized as one of the etiologies.<xref ref-type="bibr" rid="article-21640.r111">[111]</xref><xref ref-type="bibr" rid="article-21640.r112">[112]</xref> Trials of fecal microbiota transplantation are an exciting, relatively safe, and rapidly growing treatment modality that is currently undergoing experimentation to manage multiple medical conditions, including CFS.<xref ref-type="bibr" rid="article-21640.r113">[113]</xref><xref ref-type="bibr" rid="article-21640.r114">[114]</xref> The process involves the transfer of feces from a healthy donor into a patient's gut.<xref ref-type="bibr" rid="article-21640.r115">[115]</xref> In recent years, numerous studies have shown significant symptom relief in these patients after the fecal microbiota transfer provides promising therapeutic insights.<xref ref-type="bibr" rid="article-21640.r116">[116]</xref><xref ref-type="bibr" rid="article-21640.r117">[117]</xref></p>
        <p>Even though there has been&#x000a0;some success with the fecal microbiota, it is still too early to conclude anything. However, it opens doors for future research in this direction.</p>
      </sec>
      <sec id="article-21640.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Chronic fatigue syndrome can potentially affect the instrumental activities of daily living (IADLs), such as cleaning, laundry, driving, and managing finances.<xref ref-type="bibr" rid="article-21640.r118">[118]</xref>&#x000a0;Hence, the providers must be able to diagnose this condition but, at the same time, also be able to differentiate it from other commonly encountered disorders in clinical practice, which can have overlapping presentations.</p>
        <p>
<bold>Chronic Fatigue</bold>
</p>
        <p>Even though chronic fatigue syndrome has fatigue as one of the three mandatory symptoms, it is a complex multisystem neurological disease with evidence of inflammation in the brain, hence the term myalgic encephalomyelitis.<xref ref-type="bibr" rid="article-21640.r119">[119]</xref>&#x000a0;On the other hand, chronic fatigue lacks the associated post-exertional malaise, unrefreshing sleep, and cognitive impairment.<xref ref-type="bibr" rid="article-21640.r119">[119]</xref>&#x000a0;To minimize the confusion with the terminology, the institute of medicine (IOM) has even suggested switching the terminology from chronic fatigue syndrome to "systemic exertion intolerance disease (SEID)" instead of CFS.<xref ref-type="bibr" rid="article-21640.r1">[1]</xref></p>
        <p>
<bold>Rheumatological Disorders</bold>
</p>
        <p>Fibromyalgia, polymyalgia rheumatica, polymyositis, and autoimmune disorders such as systemic lupus erythematosus,&#x000a0;rheumatoid arthritis, and Sjogren syndrome present a significant diagnostic dilemma for the provider.<xref ref-type="bibr" rid="article-21640.r120">[120]</xref><xref ref-type="bibr" rid="article-21640.r121">[121]</xref><xref ref-type="bibr" rid="article-21640.r122">[122]</xref>&#x000a0;It requires proper history, clinical examination, and laboratory testing for autoantibodies before arriving at the correct diagnosis.</p>
        <p>
<bold>Psychiatric Disorders</bold>
</p>
        <p>Roughly 20% of the patients presenting to primary care clinics have an underlying undiagnosed depressive illness, and targeted mental health history is critical.<xref ref-type="bibr" rid="article-21640.r123">[123]</xref>&#x000a0;There could be a range of undiagnosed or underdiagnosed disorders like major depressive disorder, bipolar disorder, eating disorder, schizophrenia, somatoform disorders, and substance abuse. It is of the utmost importance to remember that in the elderly, symptoms of fatigue, unrefreshing sleep, and cognitive decline can be very much part of the symptom complex of late-onset depression.<xref ref-type="bibr" rid="article-21640.r124">[124]</xref></p>
        <p>
<bold>Endocrine Disorders</bold>
</p>
        <p>There could be adrenal abnormalities (Addison disease, adrenal insufficiency, Cushing disease), thyroid abnormalities (both hypothyroidism and hyperthyroidism), and diabetes mellitus, which can mimic symptoms of chronic fatigue syndrome.</p>
        <p>
<bold>Hematological and Oncologic Disorders</bold>
</p>
        <p>Undiagnosed malignancies can present with symptoms of fatigue and warrant a search for underlying cancer with age-appropriate screening. However, age alone should not be the only determining criterion for ordering these screenings.<xref ref-type="bibr" rid="article-21640.r125">[125]</xref>&#x000a0;Anemia from any cause can present with excessive tiredness and fatigue.<xref ref-type="bibr" rid="article-21640.r126">[126]</xref><xref ref-type="bibr" rid="article-21640.r127">[127]</xref><xref ref-type="bibr" rid="article-21640.r128">[128]</xref><xref ref-type="bibr" rid="article-21640.r129">[129]</xref></p>
        <p>
<bold>Infectious Diseases</bold>
</p>
        <p>Infectious diseases like the human immunodeficiency virus, tuberculosis, and chronic hepatitis can have ongoing fatigue as their initial presentation.</p>
        <p>
<bold>Gastrointestinal Disorders</bold>
</p>
        <p>Inflammatory bowel disease can present with chronic fatigue symptoms.<xref ref-type="bibr" rid="article-21640.r130">[130]</xref>&#x000a0;Celiac disease can present with fatigue and sometimes even without gastrointestinal symptoms.</p>
        <p>
<bold>Neurological Disorders</bold>
</p>
        <p>Fatigue is the main presenting feature of multiple sclerosis.<xref ref-type="bibr" rid="article-21640.r131">[131]</xref>&#x000a0;Dementia, which has cognitive impairment as its major presentation, can cause a diagnostic dilemma, as can pseudodementia.</p>
        <p>
<bold>Age-related Orthostatic Hypotension</bold>
</p>
        <p>It is again imperative to recognize that there are age-related changes in blood vessels, causing decreased autonomic responsiveness, which worsens with inadequate fluid intake and polypharmacy.<xref ref-type="bibr" rid="article-21640.r132">[132]</xref></p>
        <p>
<bold>Respiratory Disorders</bold>
</p>
        <p>Chronic respiratory conditions like chronic obstructive pulmonary disease (COPD)&#x000a0;and sarcoidosis can present with chronic fatigue.<xref ref-type="bibr" rid="article-21640.r133">[133]</xref></p>
        <p>
<bold>Sleep Apnea</bold>
</p>
        <p>Undiagnosed obstructive sleep apnea can present with fatigue and unrefreshing sleep, two of the main diagnostic criteria for chronic fatigue syndrome. This is diagnosed by polysomnography.<xref ref-type="bibr" rid="article-21640.r134">[134]</xref></p>
      </sec>
      <sec id="article-21640.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Chronic fatigue syndrome has no cure, and the symptoms can persist for years. Its clinical course fluctuates between remissions and relapses. According to one prospective study, around 50% of patients with CFS&#x000a0;may return to part-time or full-time work.<xref ref-type="bibr" rid="article-21640.r135">[135]</xref>&#x000a0;Factors associated with poor prognosis include longer&#x000a0;duration of illness, comorbid depression, severe fatigue, and anxiety.<xref ref-type="bibr" rid="article-21640.r136">[136]</xref>&#x000a0;</p>
        <p>Favorable&#x000a0;outcomes are associated with less severity of fatigue at baseline, a better sense of control over symptoms, and the absence of any attribution of the&#x000a0;disease to a physical cause.<xref ref-type="bibr" rid="article-21640.r137">[137]</xref>&#x000a0;Although a&#x000a0;considerable burden of morbidity is linked with CFS, there is no remarkable evidence of&#x000a0;increased mortality.</p>
      </sec>
      <sec id="article-21640.s11" sec-type="Complications">
        <title>Complications</title>
        <p>As in any chronic illness, it is very common for people with chronic fatigue syndrome to experience depression, stress, and anxiety. While chronic fatigue syndrome is not a psychological&#x000a0;condition, it is debilitating. Good days or bad days can be unpredictable. Patients experience ongoing challenges in their education, career,&#x000a0;and personal life, as they work to balance how they feel about their obligations and desires.&#x000a0;Many people with CFS describe feeling demoralized or even, at times, hopeless.</p>
      </sec>
      <sec id="article-21640.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Living with chronic fatigue syndrome can be stressful, as the symptoms can affect the quality of life. Most people are generally healthy and active before developing CFS, making it particularly distressing.&#x000a0;The most crucial factor for patients to successfully cope with CFS is establishing a strong relationship with an experienced health care provider. Having a provider that patients can trust, who listens to&#x000a0;them and understands that their symptoms are real, can be validating and helpful. While it is discouraging to know that there is no quick cure for CFS, an experienced provider can work with the patient to find ways to manage&#x000a0;their symptoms and maximize their quality of life.</p>
      </sec>
      <sec id="article-21640.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Chronic fatigue syndrome frequently poses a diagnostic dilemma. The hallmark symptom is the post-exertional fatigue associated with numerous neurological, cardiovascular, respiratory, and gastrointestinal complaints. Patients can also exhibit uncontrolled anxiety, panic attacks, and impaired social functioning. Chronic fatigue syndrome is a diagnosis made on clinical examination after excluding other possible etiologies. Therefore, it&#x000a0;is essential to consult with an interprofessional team of specialists, including a pain specialist, psychiatrist, psychotherapist, nursing staff, other clinicians (MDs, DOs, NPs, or PAs), and possibly a physical therapist and/or pharmacist, depending on the treatment course taken. Even though chronic fatigue syndrome has fatigue as one of the three mandatory symptoms, it is a complex multisystem neurological disease with evidence of inflammation in the brain. As the term myalgic encephalomyelitis indicates, a neurology consultation can be useful when indicated.</p>
        <p>All interprofessional team members must follow the patient and record and progress or deterioration of their condition and inform other team members so changes in the management approach can occur if necessary. Open communication and diligent documentation are essential to the interprofessional strategy so that all team members can access the same patient data. This will help drive better outcomes. [Level 5]</p>
        <p>The primary non-pharmacological treatment modalities are cognitive behavior therapy and graded exercise therapy. There is a wide range of medications that can be used for CFS. They range from NSAIDs to antidepressants; therefore, a pharmacy consult is in order. The pharmacist can perform medication reconciliation and check medication dosing, reporting any concerns to the other team members as appropriate.</p>
        <p>A broad range of differential diagnoses should be considered before diagnosing chronic fatigue syndrome. However, consultation with an interprofessional&#x000a0;healthcare team is recommended to improve outcomes.</p>
      </sec>
      <sec id="article-21640.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21640&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21640">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/chronic-fatigue-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21640">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21640/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21640">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21640.s15">
        <title>References</title>
        <ref id="article-21640.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <article-title>Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness.</article-title>
            <source>Mil Med</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>180</volume>
            <issue>7</issue>
            <fpage>721</fpage>
            <page-range>721-3</page-range>
            <pub-id pub-id-type="pmid">26126237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montoya</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Maecker</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Rosenberg-Hasson</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Valencia</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Younger</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Tato</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Cytokine signature associated with disease severity in chronic fatigue syndrome patients.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2017</year>
            <month>Aug</month>
            <day>22</day>
            <volume>114</volume>
            <issue>34</issue>
            <fpage>E7150</fpage>
            <page-range>E7150-E7158</page-range>
            <pub-id pub-id-type="pmid">28760971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cortes Rivera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mastronardi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Silva-Aldana</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Arcos-Burgos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lidbury</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review.</article-title>
            <source>Diagnostics (Basel)</source>
            <year>2019</year>
            <month>Aug</month>
            <day>07</day>
            <volume>9</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">31394725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Timbol</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Baraniuk</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Chronic fatigue syndrome in the emergency department.</article-title>
            <source>Open Access Emerg Med</source>
            <year>2019</year>
            <volume>11</volume>
            <fpage>15</fpage>
            <page-range>15-28</page-range>
            <pub-id pub-id-type="pmid">30666170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hickie</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Heath</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: a twin study.</article-title>
            <source>Psychol Med</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>269</fpage>
            <page-range>269-77</page-range>
            <pub-id pub-id-type="pmid">10218918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hickie</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kirk</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Unique genetic and environmental determinants of prolonged fatigue: a twin study.</article-title>
            <source>Psychol Med</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>259</fpage>
            <page-range>259-68</page-range>
            <pub-id pub-id-type="pmid">10218917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buchwald</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Herrell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ashton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Belcourt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schmaling</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Neale</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A twin study of chronic fatigue.</article-title>
            <source>Psychosom Med</source>
            <year>2001</year>
            <season>Nov-Dec</season>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>936</fpage>
            <page-range>936-43</page-range>
            <pub-id pub-id-type="pmid">11719632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whistler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Unger</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Vernon</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects.</article-title>
            <source>BMC Physiol</source>
            <year>2005</year>
            <month>Mar</month>
            <day>24</day>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <pub-id pub-id-type="pmid">15790422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gough</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Christmas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mattey</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Main</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Enlander</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Honeybourne</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ayres</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Nutt</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis.</article-title>
            <source>J Clin Pathol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>156</fpage>
            <page-range>156-64</page-range>
            <pub-id pub-id-type="pmid">19955554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <article-title>Myalgic encephalomyelitis: International Consensus Criteria.</article-title>
            <source>J Intern Med</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>282</volume>
            <issue>4</issue>
            <fpage>353</fpage>
            <pub-id pub-id-type="pmid">28929634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DuBois</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Seeley</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Brus</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ballow</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Harada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bechtold</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Purtilo</surname>
                <given-names>DT</given-names>
              </name>
            </person-group>
            <article-title>Chronic mononucleosis syndrome.</article-title>
            <source>South Med J</source>
            <year>1984</year>
            <month>Nov</month>
            <volume>77</volume>
            <issue>11</issue>
            <fpage>1376</fpage>
            <page-range>1376-82</page-range>
            <pub-id pub-id-type="pmid">6093268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobson</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>McIntosh</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Chronic parvovirus B19 infection resulting in chronic fatigue syndrome: case history and review.</article-title>
            <source>Clin Infect Dis</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>1048</fpage>
            <page-range>1048-51</page-range>
            <pub-id pub-id-type="pmid">9195056</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ortega-Hernandez</surname>
                <given-names>OD</given-names>
              </name>
              <name>
                <surname>Shoenfeld</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>1173</volume>
            <fpage>600</fpage>
            <page-range>600-9</page-range>
            <pub-id pub-id-type="pmid">19758205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manian</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?</article-title>
            <source>Clin Infect Dis</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>448</fpage>
            <page-range>448-53</page-range>
            <pub-id pub-id-type="pmid">7811864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loebel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Strohschein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Giannini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Koelsch</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Doebis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Unterwalder</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>von Baehr</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Reinke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knops</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanitsch</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Meisel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Volk</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Scheibenbogen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>e85387</fpage>
            <pub-id pub-id-type="pmid">24454857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loebel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eckey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sotzny</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grabowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zerweck</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Holenya</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hanitsch</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Wittke</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Borchmann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>R&#x000fc;ffer</surname>
                <given-names>JU</given-names>
              </name>
              <name>
                <surname>Hiepe</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ruprecht</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Behrends</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Meindl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Volk</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Reimer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Scheibenbogen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.</article-title>
            <source>PLoS One</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>e0179124</fpage>
            <pub-id pub-id-type="pmid">28604802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ablashi</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Eastman</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Owen</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Roman</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zabriskie</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Whitman</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.</article-title>
            <source>J Clin Virol</source>
            <year>2000</year>
            <month>May</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>179</fpage>
            <page-range>179-91</page-range>
            <pub-id pub-id-type="pmid">10738137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapenko</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Krumina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kozireva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nora</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Sultanova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Viksna</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Murovska</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome.</article-title>
            <source>J Clin Virol</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>37 Suppl 1</volume>
            <fpage>S47</fpage>
            <page-range>S47-51</page-range>
            <pub-id pub-id-type="pmid">17276369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fr&#x000e9;mont</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Metzger</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rady</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hulstaert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>De Meirleir</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients.</article-title>
            <source>In Vivo</source>
            <year>2009</year>
            <season>Mar-Apr</season>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>209</fpage>
            <page-range>209-13</page-range>
            <pub-id pub-id-type="pmid">19414405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aoki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kuratsune</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shimada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Oka</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamadera</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Iwashita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tokuno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nibuya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tanichi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mukai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mitani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakayama</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Human herpesvirus 6 and 7 are biomarkers for fatigue, which distinguish between physiological fatigue and pathological fatigue.</article-title>
            <source>Biochem Biophys Res Commun</source>
            <year>2016</year>
            <month>Sep</month>
            <day>09</day>
            <volume>478</volume>
            <issue>1</issue>
            <fpage>424</fpage>
            <page-range>424-430</page-range>
            <pub-id pub-id-type="pmid">27396623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kerr</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.</article-title>
            <source>J Clin Pathol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>279</fpage>
            <page-range>279-91</page-range>
            <pub-id pub-id-type="pmid">26644521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kerr</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Barah</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mattey</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Laing</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hopkins</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Hutchinson</surname>
                <given-names>IV</given-names>
              </name>
              <name>
                <surname>Tyrrell</surname>
                <given-names>DAJ</given-names>
              </name>
            </person-group>
            <article-title>Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue.</article-title>
            <source>J Gen Virol</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>82</volume>
            <issue>Pt 12</issue>
            <fpage>3011</fpage>
            <page-range>3011-3019</page-range>
            <pub-id pub-id-type="pmid">11714978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barker</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fujimura</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Fadem</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Landay</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Immunologic abnormalities associated with chronic fatigue syndrome.</article-title>
            <source>Clin Infect Dis</source>
            <year>1994</year>
            <month>Jan</month>
            <volume>18 Suppl 1</volume>
            <fpage>S136</fpage>
            <page-range>S136-41</page-range>
            <pub-id pub-id-type="pmid">8148441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bradley</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls.</article-title>
            <source>Clin Exp Immunol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>172</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-80</page-range>
            <pub-id pub-id-type="pmid">23480187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mensah</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berkovitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Leandro</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cambridge</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.</article-title>
            <source>Clin Exp Immunol</source>
            <year>2016</year>
            <month>May</month>
            <volume>184</volume>
            <issue>2</issue>
            <fpage>237</fpage>
            <page-range>237-47</page-range>
            <pub-id pub-id-type="pmid">26646713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guenther</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Loebel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mooslechner</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Knops</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanitsch</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Grabowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wittke</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Meisel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Unterwalder</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Volk</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Scheibenbogen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome.</article-title>
            <source>Hum Immunol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>76</volume>
            <issue>10</issue>
            <fpage>729</fpage>
            <page-range>729-35</page-range>
            <pub-id pub-id-type="pmid">26429318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f6;bel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mooslechner</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>G&#x000fc;nther</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Letsch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hanitsch</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Grabowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Meisel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Volk</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Scheibenbogen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome.</article-title>
            <source>J Transl Med</source>
            <year>2015</year>
            <month>Aug</month>
            <day>14</day>
            <volume>13</volume>
            <fpage>264</fpage>
            <pub-id pub-id-type="pmid">26272340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Konstantinov</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>von Mikecz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Buchwald</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gerace</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome.</article-title>
            <source>J Clin Invest</source>
            <year>1996</year>
            <month>Oct</month>
            <day>15</day>
            <volume>98</volume>
            <issue>8</issue>
            <fpage>1888</fpage>
            <page-range>1888-96</page-range>
            <pub-id pub-id-type="pmid">8878441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishikai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tomomatsu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hankins</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Takagi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miyachi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kosaka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Akiya</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>40</volume>
            <issue>7</issue>
            <fpage>806</fpage>
            <page-range>806-10</page-range>
            <pub-id pub-id-type="pmid">11477286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loebel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grabowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Heidecke</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hanitsch</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Wittke</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Meisel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reinke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Volk</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Fluge</surname>
                <given-names>&#x000d8;</given-names>
              </name>
              <name>
                <surname>Mella</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Scheibenbogen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Antibodies to &#x003b2; adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.</article-title>
            <source>Brain Behav Immun</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>52</volume>
            <fpage>32</fpage>
            <page-range>32-39</page-range>
            <pub-id pub-id-type="pmid">26399744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>von Mikecz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Konstantinov</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Buchwald</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Gerace</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome.</article-title>
            <source>Arthritis Rheum</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>295</fpage>
            <page-range>295-305</page-range>
            <pub-id pub-id-type="pmid">9041942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Flaherty</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rospenda</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Chronic fatigue syndrome: have flawed assumptions been derived from treatment-based studies?</article-title>
            <source>Am J Public Health</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>84</volume>
            <issue>2</issue>
            <fpage>282</fpage>
            <page-range>282-4</page-range>
            <pub-id pub-id-type="pmid">8296954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steele</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dobbins</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Reyes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Randall</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Koppelman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of chronic fatigue in San Francisco.</article-title>
            <source>Am J Med</source>
            <year>1998</year>
            <month>Sep</month>
            <day>28</day>
            <volume>105</volume>
            <issue>3A</issue>
            <fpage>83S</fpage>
            <page-range>83S-90S</page-range>
            <pub-id pub-id-type="pmid">9790487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fukuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dobbins</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wilcox</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Smallwood</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>An epidemiologic study of fatigue with relevance for the chronic fatigue syndrome.</article-title>
            <source>J Psychiatr Res</source>
            <year>1997</year>
            <season>Jan-Feb</season>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-29</page-range>
            <pub-id pub-id-type="pmid">9201644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wessely</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chalder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study.</article-title>
            <source>Am J Public Health</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>87</volume>
            <issue>9</issue>
            <fpage>1449</fpage>
            <page-range>1449-55</page-range>
            <pub-id pub-id-type="pmid">9314795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reyes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gary</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Dobbins</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Randall</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Connell</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Mawle</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Schmid</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Schonberger</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Gunn</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993.</article-title>
            <source>MMWR CDC Surveill Summ</source>
            <year>1997</year>
            <month>Feb</month>
            <day>21</day>
            <volume>46</volume>
            <issue>2</issue>
            <fpage>1</fpage>
            <page-range>1-13</page-range>
            <pub-id pub-id-type="pmid">12412768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buchwald</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Umali</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Umali</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kith</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pearlman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Komaroff</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system.</article-title>
            <source>Ann Intern Med</source>
            <year>1995</year>
            <month>Jul</month>
            <day>15</day>
            <volume>123</volume>
            <issue>2</issue>
            <fpage>81</fpage>
            <page-range>81-8</page-range>
            <pub-id pub-id-type="pmid">7778839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lawrie</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Pelosi</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Chronic fatigue syndrome in the community. Prevalence and associations.</article-title>
            <source>Br J Psychiatry</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>166</volume>
            <issue>6</issue>
            <fpage>793</fpage>
            <page-range>793-7</page-range>
            <pub-id pub-id-type="pmid">7663830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bierl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nisenbaum</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hoaglin</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Randall</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Unger</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>Regional distribution of fatiguing illnesses in the United States: a pilot study.</article-title>
            <source>Popul Health Metr</source>
            <year>2004</year>
            <month>Feb</month>
            <day>04</day>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">14761250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vincent</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brimmer</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Whipple</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Boneva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lahr</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Maloney</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>St Sauver</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted County, Minnesota, as estimated using the Rochester Epidemiology Project.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>87</volume>
            <issue>12</issue>
            <fpage>1145</fpage>
            <page-range>1145-52</page-range>
            <pub-id pub-id-type="pmid">23140977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jason</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Richman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rademaker</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Plioplys</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>McCready</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Plioplys</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A community-based study of chronic fatigue syndrome.</article-title>
            <source>Arch Intern Med</source>
            <year>1999</year>
            <month>Oct</month>
            <day>11</day>
            <volume>159</volume>
            <issue>18</issue>
            <fpage>2129</fpage>
            <page-range>2129-37</page-range>
            <pub-id pub-id-type="pmid">10527290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lorusso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mikhaylova</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Capelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ngonga</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Ricevuti</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Immunological aspects of chronic fatigue syndrome.</article-title>
            <source>Autoimmun Rev</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>287</fpage>
            <page-range>287-91</page-range>
            <pub-id pub-id-type="pmid">18801465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marshall-Gradisnik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Huth</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chacko</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Staines</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome.</article-title>
            <source>Appl Clin Genet</source>
            <year>2016</year>
            <volume>9</volume>
            <fpage>39</fpage>
            <page-range>39-47</page-range>
            <pub-id pub-id-type="pmid">27099524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennedy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Spence</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>McLaren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Underwood</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Belch</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms.</article-title>
            <source>Free Radic Biol Med</source>
            <year>2005</year>
            <month>Sep</month>
            <day>01</day>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>584</fpage>
            <page-range>584-9</page-range>
            <pub-id pub-id-type="pmid">16085177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennedy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Underwood</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Belch</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Biochemical and vascular aspects of pediatric chronic fatigue syndrome.</article-title>
            <source>Arch Pediatr Adolesc Med</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>164</volume>
            <issue>9</issue>
            <fpage>817</fpage>
            <page-range>817-23</page-range>
            <pub-id pub-id-type="pmid">20819963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maes</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms.</article-title>
            <source>Curr Opin Psychiatry</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-83</page-range>
            <pub-id pub-id-type="pmid">19127706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morris</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maes</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.</article-title>
            <source>Metab Brain Dis</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-36</page-range>
            <pub-id pub-id-type="pmid">24557875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schoeman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Van Der Westhuizen</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Erasmus</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>van Dyk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Knowles</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Al-Ali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Newton</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Elson</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.</article-title>
            <source>BMC Med Genet</source>
            <year>2017</year>
            <month>Mar</month>
            <day>16</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <pub-id pub-id-type="pmid">28302057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Billing-Ross</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Germain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Keinan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Hanson</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.</article-title>
            <source>J Transl Med</source>
            <year>2016</year>
            <month>Jan</month>
            <day>20</day>
            <volume>14</volume>
            <fpage>19</fpage>
            <pub-id pub-id-type="pmid">26791940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finsterer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zarrouk-Mahjoub</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Is chronic fatigue syndrome truly associated with haplogroups or mtDNA single nucleotide polymorphisms?</article-title>
            <source>J Transl Med</source>
            <year>2016</year>
            <month>Jun</month>
            <day>18</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>182</fpage>
            <pub-id pub-id-type="pmid">27317438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nijs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>De Meirleir</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Impairments of the 2-5A synthetase/RNase L pathway in chronic fatigue syndrome.</article-title>
            <source>In Vivo</source>
            <year>2005</year>
            <season>Nov-Dec</season>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>1013</fpage>
            <page-range>1013-21</page-range>
            <pub-id pub-id-type="pmid">16277015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Poli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cuapio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Briquemont</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Iserentant</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ollert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zimmer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Human CD56bright NK Cells: An Update.</article-title>
            <source>J Immunol</source>
            <year>2016</year>
            <month>Apr</month>
            <day>01</day>
            <volume>196</volume>
            <issue>7</issue>
            <fpage>2923</fpage>
            <page-range>2923-31</page-range>
            <pub-id pub-id-type="pmid">26994304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Michel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Th&#x000e9;r&#x000e9;sine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andr&#x000e8;s</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hentges</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zimmer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>CD56bright natural killer (NK) cells: an important NK cell subset.</article-title>
            <source>Immunology</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>126</volume>
            <issue>4</issue>
            <fpage>458</fpage>
            <page-range>458-65</page-range>
            <pub-id pub-id-type="pmid">19278419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brenu</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Huth</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Hardcastle</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ramos</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Staines</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Marshall-Gradisnik</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.</article-title>
            <source>Int Immunol</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>233</fpage>
            <page-range>233-42</page-range>
            <pub-id pub-id-type="pmid">24343819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Twisk</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Kubera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ringel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Leunis</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Geffard</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome.</article-title>
            <source>J Affect Disord</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>136</volume>
            <issue>3</issue>
            <fpage>909</fpage>
            <page-range>909-17</page-range>
            <pub-id pub-id-type="pmid">21967891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mihaylova</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Leunis</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability.</article-title>
            <source>J Affect Disord</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>99</volume>
            <issue>1-3</issue>
            <fpage>237</fpage>
            <page-range>237-40</page-range>
            <pub-id pub-id-type="pmid">17007934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sotzny</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Blanco</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Capelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Castro-Marrero</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Murovska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scheibenbogen</surname>
                <given-names>C</given-names>
              </name>
              <collab>European Network on ME/CFS (EUROMENE)</collab>
            </person-group>
            <article-title>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.</article-title>
            <source>Autoimmun Rev</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>601</fpage>
            <page-range>601-609</page-range>
            <pub-id pub-id-type="pmid">29635081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ortega-Hernandez</surname>
                <given-names>OD</given-names>
              </name>
              <name>
                <surname>Cuccia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozzini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bassi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Moscavitch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Diaz-Gallo</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Blank</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Agmon-Levin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shoenfeld</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: are they associated with age at onset and specific symptoms?</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>1173</volume>
            <fpage>589</fpage>
            <page-range>589-99</page-range>
            <pub-id pub-id-type="pmid">19758204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reynolds</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Lidbury</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.</article-title>
            <source>J Intern Med</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>275</volume>
            <issue>4</issue>
            <fpage>409</fpage>
            <page-range>409-17</page-range>
            <pub-id pub-id-type="pmid">24206536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakatomi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mizuno</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tazawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Onoe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kawabe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kataoka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shiomi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yamaguti</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Inaba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kuratsune</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An &#x000b9;&#x000b9;C-(R)-PK11195 PET Study.</article-title>
            <source>J Nucl Med</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>945</fpage>
            <page-range>945-50</page-range>
            <pub-id pub-id-type="pmid">24665088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Guilarte</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair.</article-title>
            <source>Pharmacol Ther</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>118</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-17</page-range>
            <pub-id pub-id-type="pmid">18374421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glassford</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).</article-title>
            <source>Front Physiol</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>88</fpage>
            <pub-id pub-id-type="pmid">28261110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Svahn</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>G&#x000f6;ransson</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Chryssanthou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sj&#x000f6;lin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Str&#x000f6;mstedt</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Induction of gliotoxin secretion in Aspergillus fumigatus by bacteria-associated molecules.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>e93685</fpage>
            <pub-id pub-id-type="pmid">24705440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamashita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Tryptophan circuit in fatigue: From blood to brain and cognition.</article-title>
            <source>Brain Res</source>
            <year>2017</year>
            <month>Nov</month>
            <day>15</day>
            <volume>1675</volume>
            <fpage>116</fpage>
            <page-range>116-126</page-range>
            <pub-id pub-id-type="pmid">28893581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cotel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Exley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cragg</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Perrier</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Serotonin spillover onto the axon initial segment of motoneurons induces central fatigue by inhibiting action potential initiation.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2013</year>
            <month>Mar</month>
            <day>19</day>
            <volume>110</volume>
            <issue>12</issue>
            <fpage>4774</fpage>
            <page-range>4774-9</page-range>
            <pub-id pub-id-type="pmid">23487756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>JZ</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Siemionow</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sahgal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yue</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Fatigue induces greater brain signal reduction during sustained than preparation phase of maximal voluntary contraction.</article-title>
            <source>Brain Res</source>
            <year>2005</year>
            <month>Sep</month>
            <day>28</day>
            <volume>1057</volume>
            <issue>1-2</issue>
            <fpage>113</fpage>
            <page-range>113-26</page-range>
            <pub-id pub-id-type="pmid">16129419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hall</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Lattie</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Antoni</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Czaja</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Perdomo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Klimas</surname>
                <given-names>NG</given-names>
              </name>
            </person-group>
            <article-title>Stress management skills, cortisol awakening response, and post-exertional malaise in Chronic Fatigue Syndrome.</article-title>
            <source>Psychoneuroendocrinology</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>49</volume>
            <fpage>26</fpage>
            <page-range>26-31</page-range>
            <pub-id pub-id-type="pmid">25049069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wallis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ball</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McKechnie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Butt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Bruck</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review.</article-title>
            <source>J Transl Med</source>
            <year>2017</year>
            <month>Jun</month>
            <day>07</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>129</fpage>
            <pub-id pub-id-type="pmid">28592308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vermeulen</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Kurk</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Visser</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Sluiter</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Scholte</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity.</article-title>
            <source>J Transl Med</source>
            <year>2010</year>
            <month>Oct</month>
            <day>11</day>
            <volume>8</volume>
            <fpage>93</fpage>
            <pub-id pub-id-type="pmid">20937116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacDonald</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Osterholm</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>LeDell</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Schenck</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Persing</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome.</article-title>
            <source>Am J Med</source>
            <year>1996</year>
            <month>May</month>
            <volume>100</volume>
            <issue>5</issue>
            <fpage>548</fpage>
            <page-range>548-54</page-range>
            <pub-id pub-id-type="pmid">8644768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salit</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Precipitating factors for the chronic fatigue syndrome.</article-title>
            <source>J Psychiatr Res</source>
            <year>1997</year>
            <season>Jan-Feb</season>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-65</page-range>
            <pub-id pub-id-type="pmid">9201648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rowe</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Underhill</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Gurwitt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Medow</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Speight</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Vallings</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rowe</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer.</article-title>
            <source>Front Pediatr</source>
            <year>2017</year>
            <volume>5</volume>
            <fpage>121</fpage>
            <pub-id pub-id-type="pmid">28674681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clauw</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Perspectives on fatigue from the study of chronic fatigue syndrome and related conditions.</article-title>
            <source>PM R</source>
            <year>2010</year>
            <month>May</month>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>414</fpage>
            <page-range>414-30</page-range>
            <pub-id pub-id-type="pmid">20656623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cockshell</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Mathias</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Cognitive functioning in chronic fatigue syndrome: a meta-analysis.</article-title>
            <source>Psychol Med</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>40</volume>
            <issue>8</issue>
            <fpage>1253</fpage>
            <page-range>1253-67</page-range>
            <pub-id pub-id-type="pmid">20047703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bested</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.</article-title>
            <source>Rev Environ Health</source>
            <year>2015</year>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>223</fpage>
            <page-range>223-49</page-range>
            <pub-id pub-id-type="pmid">26613325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Komaroff</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Fagioli</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Geiger</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Doolittle</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kornish</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Gleit</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Guerriero</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>An examination of the working case definition of chronic fatigue syndrome.</article-title>
            <source>Am J Med</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>100</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <page-range>56-64</page-range>
            <pub-id pub-id-type="pmid">8579088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharpe</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Archard</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Banatvala</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Borysiewicz</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Clare</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>David</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Hawton</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>A report--chronic fatigue syndrome: guidelines for research.</article-title>
            <source>J R Soc Med</source>
            <year>1991</year>
            <month>Feb</month>
            <volume>84</volume>
            <issue>2</issue>
            <fpage>118</fpage>
            <page-range>118-21</page-range>
            <pub-id pub-id-type="pmid">1999813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Afari</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Buchwald</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Chronic fatigue syndrome: a review.</article-title>
            <source>Am J Psychiatry</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>160</volume>
            <issue>2</issue>
            <fpage>221</fpage>
            <page-range>221-36</page-range>
            <pub-id pub-id-type="pmid">12562565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bombardier</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Buchwald</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use.</article-title>
            <source>Med Care</source>
            <year>1996</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>9</issue>
            <fpage>924</fpage>
            <page-range>924-30</page-range>
            <pub-id pub-id-type="pmid">8792781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>White</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Goldsmith</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Potts</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Walwyn</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>DeCesare</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Baber</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Burgess</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Bavinton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Dowd</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wilks</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McCrone</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chalder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sharpe</surname>
                <given-names>M</given-names>
              </name>
              <collab>PACE trial management group</collab>
            </person-group>
            <article-title>Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial.</article-title>
            <source>Lancet</source>
            <year>2011</year>
            <month>Mar</month>
            <day>05</day>
            <volume>377</volume>
            <issue>9768</issue>
            <fpage>823</fpage>
            <page-range>823-36</page-range>
            <pub-id pub-id-type="pmid">21334061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larun</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brurberg</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Odgaard-Jensen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Exercise therapy for chronic fatigue syndrome.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Jun</month>
            <day>24</day>
            <issue>6</issue>
            <fpage>CD003200</fpage>
            <pub-id pub-id-type="pmid">27339435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharpe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goldsmith</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Chalder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial.</article-title>
            <source>Lancet Psychiatry</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>2</volume>
            <issue>12</issue>
            <fpage>1067</fpage>
            <page-range>1067-74</page-range>
            <pub-id pub-id-type="pmid">26521770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fukuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Straus</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Hickie</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sharpe</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Dobbins</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Komaroff</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.</article-title>
            <source>Ann Intern Med</source>
            <year>1994</year>
            <month>Dec</month>
            <day>15</day>
            <volume>121</volume>
            <issue>12</issue>
            <fpage>953</fpage>
            <page-range>953-9</page-range>
            <pub-id pub-id-type="pmid">7978722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clayton</surname>
                <given-names>EW</given-names>
              </name>
            </person-group>
            <article-title>Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness.</article-title>
            <source>JAMA</source>
            <year>2015</year>
            <month>Mar</month>
            <day>17</day>
            <volume>313</volume>
            <issue>11</issue>
            <fpage>1101</fpage>
            <page-range>1101-2</page-range>
            <pub-id pub-id-type="pmid">25668027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jason</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Sunnquist</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The Development of the DePaul Symptom Questionnaire: Original, Expanded, Brief, and Pediatric Versions.</article-title>
            <source>Front Pediatr</source>
            <year>2018</year>
            <volume>6</volume>
            <fpage>330</fpage>
            <pub-id pub-id-type="pmid">30460215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nisenbaum</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Heim</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Unger</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome.</article-title>
            <source>Popul Health Metr</source>
            <year>2005</year>
            <month>Jul</month>
            <day>22</day>
            <volume>3</volume>
            <fpage>8</fpage>
            <pub-id pub-id-type="pmid">16042777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baker</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): summary of NICE guidance.</article-title>
            <source>BMJ</source>
            <year>2007</year>
            <month>Sep</month>
            <day>01</day>
            <volume>335</volume>
            <issue>7617</issue>
            <fpage>446</fpage>
            <page-range>446-8</page-range>
            <pub-id pub-id-type="pmid">17762037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilshire</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Kindlon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Courtney</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Matthees</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tuller</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Geraghty</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Rethinking the treatment of chronic fatigue syndrome-a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT.</article-title>
            <source>BMC Psychol</source>
            <year>2018</year>
            <month>Mar</month>
            <day>22</day>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">29562932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r89">
          <label>89</label>
          <element-citation publication-type="book">
            <collab>National Collaborating Centre for Primary Care (UK)</collab>
            <source>Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy): Diagnosis and Management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy) in Adults and Children [Internet]</source>
            <publisher-name>Royal College of General Practitioners (UK)</publisher-name>
            <publisher-loc>London</publisher-loc>
            <year>2007</year>
            <month>08</month>
            <pub-id pub-id-type="pmid">21563329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Dowd</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gladwell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Hollinghurst</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gregory</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.</article-title>
            <source>Health Technol Assess</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>10</volume>
            <issue>37</issue>
            <fpage>iii</fpage>
            <page-range>iii-iv, ix-x, 1-121</page-range>
            <pub-id pub-id-type="pmid">17014748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deale</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Husain</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chalder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wessely</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study.</article-title>
            <source>Am J Psychiatry</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>158</volume>
            <issue>12</issue>
            <fpage>2038</fpage>
            <page-range>2038-42</page-range>
            <pub-id pub-id-type="pmid">11729022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vos-Vromans</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Smeets</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Huijnen</surname>
                <given-names>IP</given-names>
              </name>
              <name>
                <surname>K&#x000f6;ke</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Hitters</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Rijnders</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Pont</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Winkens</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Knottnerus</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: a randomized controlled trial.</article-title>
            <source>J Intern Med</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>279</volume>
            <issue>3</issue>
            <fpage>268</fpage>
            <page-range>268-82</page-range>
            <pub-id pub-id-type="pmid">26306716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nijhof</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Bleijenberg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Uiterwaal</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kimpen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>van de Putte</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial.</article-title>
            <source>Lancet</source>
            <year>2012</year>
            <month>Apr</month>
            <day>14</day>
            <volume>379</volume>
            <issue>9824</issue>
            <fpage>1412</fpage>
            <page-range>1412-8</page-range>
            <pub-id pub-id-type="pmid">22385683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Powell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bentall</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Nye</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Patient education to encourage graded exercise in chronic fatigue syndrome. 2-year follow-up of randomised controlled trial.</article-title>
            <source>Br J Psychiatry</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>184</volume>
            <fpage>142</fpage>
            <page-range>142-6</page-range>
            <pub-id pub-id-type="pmid">14754826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moss-Morris</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sharon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tobin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Baldi</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change.</article-title>
            <source>J Health Psychol</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>245</fpage>
            <page-range>245-59</page-range>
            <pub-id pub-id-type="pmid">15723894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Sandler</surname>
                <given-names>CX</given-names>
              </name>
              <name>
                <surname>Casson</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Cassar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bogg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>BK</given-names>
              </name>
            </person-group>
            <article-title>Randomised controlled trial of online continuing education for health professionals to improve the management of chronic fatigue syndrome: a study protocol.</article-title>
            <source>BMJ Open</source>
            <year>2017</year>
            <month>May</month>
            <day>10</day>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>e014133</fpage>
            <pub-id pub-id-type="pmid">28495811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castro-Marrero</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>S&#x000e1;ez-Franc&#x000e0;s</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Santillo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alegre</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.</article-title>
            <source>Br J Pharmacol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>174</volume>
            <issue>5</issue>
            <fpage>345</fpage>
            <page-range>345-369</page-range>
            <pub-id pub-id-type="pmid">28052319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Theoharides</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Asadi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Weng</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs--important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome.</article-title>
            <source>J Clin Psychopharmacol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>403</fpage>
            <page-range>403-5</page-range>
            <pub-id pub-id-type="pmid">21694612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Degenhardt</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gisev</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cama</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Larance</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The extent and correlates of community-based pharmaceutical opioid utilisation in Australia.</article-title>
            <source>Pharmacoepidemiol Drug Saf</source>
            <year>2016</year>
            <month>May</month>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>521</fpage>
            <page-range>521-38</page-range>
            <pub-id pub-id-type="pmid">26781123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clemons</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vasiadi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kempuraj</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kourelis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vandoros</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Theoharides</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome.</article-title>
            <source>J Clin Psychopharmacol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>385</fpage>
            <page-range>385-7</page-range>
            <pub-id pub-id-type="pmid">21532369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanders</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korf</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Neuroaetiology of chronic fatigue syndrome: an overview.</article-title>
            <source>World J Biol Psychiatry</source>
            <year>2008</year>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>165</fpage>
            <page-range>165-71</page-range>
            <pub-id pub-id-type="pmid">17853290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jason</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Benton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Torres-Harding</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Muldowney</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The impact of energy modulation on physical functioning and fatigue severity among patients with ME/CFS.</article-title>
            <source>Patient Educ Couns</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>77</volume>
            <issue>2</issue>
            <fpage>237</fpage>
            <page-range>237-41</page-range>
            <pub-id pub-id-type="pmid">19356884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strayer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Brodsky</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cheney</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Salvato</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Loveless</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Elsasser</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.</article-title>
            <source>Clin Infect Dis</source>
            <year>1994</year>
            <month>Jan</month>
            <volume>18 Suppl 1</volume>
            <fpage>S88</fpage>
            <page-range>S88-95</page-range>
            <pub-id pub-id-type="pmid">8148460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brook</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Bannister</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Weir</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Interferon-alpha therapy for patients with chronic fatigue syndrome.</article-title>
            <source>J Infect Dis</source>
            <year>1993</year>
            <month>Sep</month>
            <volume>168</volume>
            <issue>3</issue>
            <fpage>791</fpage>
            <page-range>791-2</page-range>
            <pub-id pub-id-type="pmid">8354926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cleare</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chalder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hotopf</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wessely</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Chronic fatigue syndrome.</article-title>
            <source>BMJ Clin Evid</source>
            <year>2015</year>
            <month>Sep</month>
            <day>28</day>
            <volume>2015</volume>
            <pub-id pub-id-type="pmid">26415100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chambers</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bagnall</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hempel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Forbes</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review.</article-title>
            <source>J R Soc Med</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>99</volume>
            <issue>10</issue>
            <fpage>506</fpage>
            <page-range>506-20</page-range>
            <pub-id pub-id-type="pmid">17021301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Haney</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>McDonagh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pappas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Daeges</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wasson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.</article-title>
            <source>Ann Intern Med</source>
            <year>2015</year>
            <month>Jun</month>
            <day>16</day>
            <volume>162</volume>
            <issue>12</issue>
            <fpage>841</fpage>
            <page-range>841-50</page-range>
            <pub-id pub-id-type="pmid">26075755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whiting</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bagnall</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sowden</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Cornell</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Mulrow</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Ram&#x000ed;rez</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Interventions for the treatment and management of chronic fatigue syndrome: a systematic review.</article-title>
            <source>JAMA</source>
            <year>2001</year>
            <month>Sep</month>
            <day>19</day>
            <volume>286</volume>
            <issue>11</issue>
            <fpage>1360</fpage>
            <page-range>1360-8</page-range>
            <pub-id pub-id-type="pmid">11560542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fluge</surname>
                <given-names>&#x000d8;</given-names>
              </name>
              <name>
                <surname>Bruland</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Risa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Storstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kristoffersen</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Sapkota</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>N&#x000e6;ss</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dahl</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Nyland</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mella</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.</article-title>
            <source>PLoS One</source>
            <year>2011</year>
            <volume>6</volume>
            <issue>10</issue>
            <fpage>e26358</fpage>
            <pub-id pub-id-type="pmid">22039471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fluge</surname>
                <given-names>&#x000d8;</given-names>
              </name>
              <name>
                <surname>Rekeland</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Lien</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Th&#x000fc;rmer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Borchgrevink</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Sch&#x000e4;fer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>S&#x000f8;rland</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>A&#x000df;mus</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ktoridou-Valen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Herder</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gotaas</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Kvammen</surname>
                <given-names>&#x000d8;</given-names>
              </name>
              <name>
                <surname>Baranowska</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bohnen</surname>
                <given-names>LMLJ</given-names>
              </name>
              <name>
                <surname>Martinsen</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Lonar</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Solvang</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Gya</surname>
                <given-names>AES</given-names>
              </name>
              <name>
                <surname>Bruland</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Risa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Alme</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dahl</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mella</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.</article-title>
            <source>Ann Intern Med</source>
            <year>2019</year>
            <month>May</month>
            <day>07</day>
            <volume>170</volume>
            <issue>9</issue>
            <fpage>585</fpage>
            <page-range>585-593</page-range>
            <pub-id pub-id-type="pmid">30934066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Br&#x000fc;ssow</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Biome engineering-2020.</article-title>
            <source>Microb Biotechnol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>553</fpage>
            <page-range>553-63</page-range>
            <pub-id pub-id-type="pmid">27471167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smits</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Bouter</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>de Vos</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Borody</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Nieuwdorp</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic potential of fecal microbiota transplantation.</article-title>
            <source>Gastroenterology</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>145</volume>
            <issue>5</issue>
            <fpage>946</fpage>
            <page-range>946-53</page-range>
            <pub-id pub-id-type="pmid">24018052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bibb&#x000f2;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ianiro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gasbarrini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cammarota</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Fecal microbiota transplantation: past, present and future perspectives.</article-title>
            <source>Minerva Gastroenterol Dietol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>63</volume>
            <issue>4</issue>
            <fpage>420</fpage>
            <page-range>420-430</page-range>
            <pub-id pub-id-type="pmid">28927251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r114">
          <label>114</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giloteaux</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Goodrich</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Walters</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ley</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Hanson</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.</article-title>
            <source>Microbiome</source>
            <year>2016</year>
            <month>Jun</month>
            <day>23</day>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <pub-id pub-id-type="pmid">27338587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r115">
          <label>115</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fr&#x000e9;mont</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Coomans</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Massart</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Meirleir</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients.</article-title>
            <source>Anaerobe</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>22</volume>
            <fpage>50</fpage>
            <page-range>50-6</page-range>
            <pub-id pub-id-type="pmid">23791918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r116">
          <label>116</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Navaneetharaja</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Wileman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Carding</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?</article-title>
            <source>J Clin Med</source>
            <year>2016</year>
            <month>Jun</month>
            <day>06</day>
            <volume>5</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">27275835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r117">
          <label>117</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wallis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Butt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ball</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Bruck</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Support for the microgenderome invites enquiry into sex differences.</article-title>
            <source>Gut Microbes</source>
            <year>2017</year>
            <month>Jan</month>
            <day>02</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-52</page-range>
            <pub-id pub-id-type="pmid">27808584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r118">
          <label>118</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Guo</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Sapra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Instrumental Activity of Daily Living</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>11</month>
            <day>14</day>
            <pub-id pub-id-type="pmid">31985920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r119">
          <label>119</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Treisman</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Identification and purification of a polypeptide that binds to the c-fos serum response element.</article-title>
            <source>EMBO J</source>
            <year>1987</year>
            <month>Sep</month>
            <volume>6</volume>
            <issue>9</issue>
            <fpage>2711</fpage>
            <page-range>2711-7</page-range>
            <pub-id pub-id-type="pmid">3119326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r120">
          <label>120</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Sugino</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nishimoto</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Cytokine networks in systemic lupus erythematosus.</article-title>
            <source>J Biomed Biotechnol</source>
            <year>2010</year>
            <volume>2010</volume>
            <fpage>676284</fpage>
            <pub-id pub-id-type="pmid">20414360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r121">
          <label>121</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Zautra</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Younger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Motivala</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Attrep</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Irwin</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue.</article-title>
            <source>Brain Behav Immun</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-32</page-range>
            <pub-id pub-id-type="pmid">17706915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r122">
          <label>122</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harboe</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tjensvoll</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Vefring</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>G&#x000f8;ransson</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Kval&#x000f8;y</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Omdal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Fatigue in primary Sj&#x000f6;gren's syndrome--a link to sickness behaviour in animals?</article-title>
            <source>Brain Behav Immun</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>8</issue>
            <fpage>1104</fpage>
            <page-range>1104-8</page-range>
            <pub-id pub-id-type="pmid">19560535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r123">
          <label>123</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stadje</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dornieden</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Biroga</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>B&#x000f6;sner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Haasenritter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Keunecke</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Viniol</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Donner-Banzhoff</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The differential diagnosis of tiredness: a systematic review.</article-title>
            <source>BMC Fam Pract</source>
            <year>2016</year>
            <month>Oct</month>
            <day>20</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>147</fpage>
            <pub-id pub-id-type="pmid">27765009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r124">
          <label>124</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sekhon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sapra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Late-Life Depression</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">31855351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r125">
          <label>125</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Budh</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Sapra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Breast Cancer Screening</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>21</day>
            <pub-id pub-id-type="pmid">32310510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r126">
          <label>126</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bower</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ganz</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Irwin</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Arevalo</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cole</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Fatigue and gene expression in human leukocytes: increased NF-&#x003ba;B and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue.</article-title>
            <source>Brain Behav Immun</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>147</fpage>
            <page-range>147-50</page-range>
            <pub-id pub-id-type="pmid">20854893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r127">
          <label>127</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwak</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Yeom</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>SY</given-names>
              </name>
            </person-group>
            <article-title>The relationship between interleukin-6, tumor necrosis factor-&#x003b1;, and fatigue in terminally ill cancer patients.</article-title>
            <source>Palliat Med</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>275</fpage>
            <page-range>275-82</page-range>
            <pub-id pub-id-type="pmid">21807751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r128">
          <label>128</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thornton</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Blakely</surname>
                <given-names>WP</given-names>
              </name>
            </person-group>
            <article-title>The pain, depression, and fatigue symptom cluster in advanced breast cancer: covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system.</article-title>
            <source>Health Psychol</source>
            <year>2010</year>
            <month>May</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>333</fpage>
            <page-range>333-7</page-range>
            <pub-id pub-id-type="pmid">20496988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r129">
          <label>129</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bower</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ganz</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Tao</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Belin</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Sepah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cole</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer.</article-title>
            <source>Clin Cancer Res</source>
            <year>2009</year>
            <month>Sep</month>
            <day>01</day>
            <volume>15</volume>
            <issue>17</issue>
            <fpage>5534</fpage>
            <page-range>5534-40</page-range>
            <pub-id pub-id-type="pmid">19706826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r130">
          <label>130</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jelsness-J&#x000f8;rgensen</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Bernklev</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Henriksen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Torp</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moum</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls.</article-title>
            <source>Inflamm Bowel Dis</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>7</issue>
            <fpage>1564</fpage>
            <page-range>1564-72</page-range>
            <pub-id pub-id-type="pmid">21674713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r131">
          <label>131</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gold</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Kr&#x000fc;ger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ziegler</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Krieger</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schulz</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Otte</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Heesen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>82</volume>
            <issue>7</issue>
            <fpage>814</fpage>
            <page-range>814-8</page-range>
            <pub-id pub-id-type="pmid">21296901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r132">
          <label>132</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sapra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhandari</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Vital Sign Assessment</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">31985994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r133">
          <label>133</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-shair</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kolsum</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Dockry</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vestbo</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD.</article-title>
            <source>Respir Res</source>
            <year>2011</year>
            <month>Jan</month>
            <day>05</day>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <pub-id pub-id-type="pmid">21208443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r134">
          <label>134</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mills</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Bardwell</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dimsdale</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Predictors of fatigue in obstructive sleep apnea.</article-title>
            <source>Sleep Breath</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>397</fpage>
            <page-range>397-9</page-range>
            <pub-id pub-id-type="pmid">18516635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r135">
          <label>135</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nyland</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Naess</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Birkeland</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Nyland</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Longitudinal follow-up of employment status in patients with chronic fatigue syndrome after mononucleosis.</article-title>
            <source>BMJ Open</source>
            <year>2014</year>
            <month>Nov</month>
            <day>26</day>
            <volume>4</volume>
            <issue>11</issue>
            <fpage>e005798</fpage>
            <pub-id pub-id-type="pmid">25428629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r136">
          <label>136</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joyce</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hotopf</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wessely</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review.</article-title>
            <source>QJM</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>90</volume>
            <issue>3</issue>
            <fpage>223</fpage>
            <page-range>223-33</page-range>
            <pub-id pub-id-type="pmid">9093600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21640.r137">
          <label>137</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cairns</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hotopf</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A systematic review describing the prognosis of chronic fatigue syndrome.</article-title>
            <source>Occup Med (Lond)</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>55</volume>
            <issue>1</issue>
            <fpage>20</fpage>
            <page-range>20-31</page-range>
            <pub-id pub-id-type="pmid">15699087</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
